Morepen Laboratories Limited (MOREPENLAB.BO)
INR 83.77
(-0.35%)
INR 83.77
(-0.35%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 6.16 Billion INR | -14.56% |
| 2022 | 4.43 Billion INR | -7.71% |
| 2021 | 4.8 Billion INR | 23.68% |
| 2020 | 3.88 Billion INR | 39.96% |
| 2019 | 2.77 Billion INR | 7.89% |
| 2018 | 2.57 Billion INR | 12.85% |
| 2017 | 2.28 Billion INR | 3.93% |
| 2016 | 2.19 Billion INR | 24.17% |
| 2015 | 1.76 Billion INR | 13.92% |
| 2014 | 1.55 Billion INR | 2.27% |
| 2013 | 1.51 Billion INR | 19.67% |
| 2012 | 1.26 Billion INR | 19.66% |
| 2011 | 1.05 Billion INR | 32.45% |
| 2010 | 799.8 Million INR | 163.15% |
| 2009 | 303.93 Million INR | 25.7% |
| 2008 | 241.78 Million INR | 8.97% |
| 2007 | 221.87 Million INR | -40.25% |
| 2006 | 371.32 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.09 Billion INR | 10.8% |
| 2023 Q1 | 1.39 Billion INR | 33.19% |
| 2023 FY | 3.78 Billion INR | -14.56% |
| 2023 Q4 | 987.85 Million INR | -42.74% |
| 2023 Q3 | 1.72 Billion INR | 15.78% |
| 2023 Q2 | 1.48 Billion INR | 6.46% |
| 2022 Q3 | 1.17 Billion INR | -7.77% |
| 2022 Q1 | 930.96 Million INR | -15.36% |
| 2022 Q2 | 1.27 Billion INR | 37.13% |
| 2022 FY | 4.43 Billion INR | -7.71% |
| 2022 Q4 | 1.05 Billion INR | -10.76% |
| 2021 FY | 4.8 Billion INR | 23.68% |
| 2021 Q3 | 1.3 Billion INR | 6.62% |
| 2021 Q4 | 1.09 Billion INR | -15.61% |
| 2021 Q1 | 1.18 Billion INR | 27.79% |
| 2021 Q2 | 1.22 Billion INR | 3.55% |
| 2020 Q2 | 1.09 Billion INR | 28.95% |
| 2020 FY | 3.88 Billion INR | 39.96% |
| 2020 Q1 | 848.65 Million INR | 35.7% |
| 2020 Q4 | 923.82 Million INR | -9.35% |
| 2020 Q3 | 1.01 Billion INR | -6.88% |
| 2019 FY | 2.77 Billion INR | 7.89% |
| 2019 Q1 | 688.41 Million INR | 6.74% |
| 2019 Q2 | 735.19 Million INR | 6.79% |
| 2019 Q3 | 727.53 Million INR | -1.04% |
| 2019 Q4 | 625.36 Million INR | -14.04% |
| 2018 Q3 | 701.31 Million INR | 9.92% |
| 2018 FY | 2.57 Billion INR | 12.85% |
| 2018 Q2 | 638.04 Million INR | 8.28% |
| 2018 Q4 | 644.92 Million INR | -8.04% |
| 2018 Q1 | 589.25 Million INR | -2.39% |
| 2017 Q3 | 576.87 Million INR | -2.59% |
| 2017 Q4 | 603.69 Million INR | 4.65% |
| 2017 FY | 2.28 Billion INR | 3.93% |
| 2017 Q1 | 507.76 Million INR | 0.0% |
| 2017 Q2 | 592.21 Million INR | 16.63% |
| 2016 FY | 2.19 Billion INR | 24.17% |
| 2015 FY | 1.76 Billion INR | 13.92% |
| 2014 FY | 1.55 Billion INR | 2.27% |
| 2013 FY | 1.51 Billion INR | 19.67% |
| 2012 Q1 | - INR | 0.0% |
| 2012 FY | 1.26 Billion INR | 19.66% |
| 2012 Q2 | - INR | 0.0% |
| 2012 Q3 | - INR | 0.0% |
| 2011 FY | 1.05 Billion INR | 32.45% |
| 2010 FY | 799.8 Million INR | 163.15% |
| 2009 FY | 303.93 Million INR | 25.7% |
| 2008 FY | 241.78 Million INR | 8.97% |
| 2007 FY | 221.87 Million INR | -40.25% |
| 2006 FY | 371.32 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Ajanta Pharma Limited | 21.06 Billion INR | 70.75% |
| Amrutanjan Health Care Limited | 1.55 Billion INR | -295.834% |
| Sigachi Industries Limited | 2 Billion INR | -207.713% |
| Bal Pharma Limited | 770.19 Million INR | -699.964% |
| Ind-Swift Laboratories Limited | 6.19 Billion INR | 0.534% |
| Medico Remedies Limited | 262.14 Million INR | -2250.342% |
| Lasa Supergenerics Limited | 121.02 Million INR | -4990.706% |
| Venus Remedies Limited | 2.18 Billion INR | -182.293% |
| Sun Pharma Advanced Research Company Limited | -602.4 Million INR | 1122.779% |
| Alpa Laboratories Limited | 188.89 Million INR | -3161.749% |
| Nectar Lifesciences Limited | 2.97 Billion INR | -107.307% |
| Shilpa Medicare Limited | 3.54 Billion INR | -73.711% |
| Aarti Drugs Limited | 8.31 Billion INR | 25.912% |
| Lupin Limited | 123.71 Billion INR | 95.02% |
| Aurobindo Pharma Limited | 154.68 Billion INR | 96.017% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 95.079% |
| Windlas Biotech Limited | 1.33 Billion INR | -360.209% |
| Suven Life Sciences Limited | -200.79 Million INR | 3168.413% |
| Eris Lifesciences Limited | 10.42 Billion INR | 40.909% |
| Valiant Laboratories Limited | -60.66 Million INR | 10256.404% |
| J. B. Chemicals & Pharmaceuticals Limited | 22.69 Billion INR | 72.858% |
| Solara Active Pharma Sciences Limited | 861.2 Million INR | -615.43% |
| Ipca Laboratories Limited | 29.8 Billion INR | 79.331% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -66.727% |
| Achyut Healthcare Limited | 4.86 Million INR | -126649.249% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 97.616% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -318.62% |
| RPG Life Sciences Limited | 2.48 Billion INR | -148.139% |
| Mankind Pharma Limited | 44.52 Billion INR | 86.161% |
| Laurus Labs Limited | 24.62 Billion INR | 74.975% |
| Piramal Pharma Limited | 24.47 Billion INR | 74.822% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -553.787% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 86.823% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 76.994% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 91.114% |
| Unichem Laboratories Limited | 4.86 Billion INR | -26.647% |
| Sequent Scientific Limited | 2.97 Billion INR | -106.843% |
| Novartis India Limited | 1.32 Billion INR | -364.336% |
| Wanbury Limited | 1.73 Billion INR | -256.011% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -49.427% |
| Wockhardt Limited | 16.24 Billion INR | 62.061% |
| Themis Medicare Limited | 1.5 Billion INR | -309.686% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -844.127% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 68.634% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 50.444% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 96.234% |
| Divi's Laboratories Limited | 32.44 Billion INR | 81.007% |
| NATCO Pharma Limited | 25.73 Billion INR | 76.06% |
| Gufic Biosciences Limited | 4.16 Billion INR | -47.834% |
| IOL Chemicals and Pharmaceuticals Limited | 4.58 Billion INR | -34.502% |
| Ind-Swift Limited | 2.17 Billion INR | -183.599% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -6.571% |
| FDC Limited | 8.33 Billion INR | 26.077% |
| Krebs Biochemicals & Industries Limited | 192.72 Million INR | -3096.896% |
| Granules India Limited | 16.79 Billion INR | 63.324% |
| Medicamen Biotech Limited | 495.49 Million INR | -1143.46% |
| Alkem Laboratories Limited | 52.29 Billion INR | 88.219% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 0.987% |
| Biofil Chemicals and Pharmaceuticals Limited | 14.57 Million INR | -42159.313% |
| Brooks Laboratories Limited | 65.62 Million INR | -9289.334% |
| Megasoft Limited | 342.07 Million INR | -1701.17% |
| ZIM Laboratories Limited | 1.26 Billion INR | -386.332% |
| Strides Pharma Science Limited | 14.38 Billion INR | 57.178% |
| Neuland Laboratories Limited | 8.24 Billion INR | 25.298% |
| Hikal Limited | 3.14 Billion INR | -96.027% |
| Indoco Remedies Limited | 6.04 Billion INR | -1.986% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -5.658% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -892.991% |
| Mangalam Drugs & Organics Limited | 703.6 Million INR | -775.673% |
| Hester Biosciences Limited | 1.27 Billion INR | -383.75% |